• Follow @TheHPRA
  • Contact us
  • As Gaeilge
The Health Products Regulatory Authority logo
My HPRA: Login Register
  • About Us
  • Medicines
  • Veterinary
  • Medical Devices
  • Cosmetics
  • Controlled Substances
  • Blood, Tissues, Organs
  • Medicines
  • Regulatory Information
  • Clinical Trials
  • GCP inspections – topics of interest
My HPRA: Login Register
  • About Us
  • Medicines
    • COVID-19 vaccines and treatments
    • Our Role
    • Medicines Information
    • Safety Information
    • Safety Notices
    • Quality Information
    • Regulatory Information
      • Classification of Medicines
      • Medicines Authorisation
      • Pharmacovigilance and Post Authorisation Safety
      • Clinical Trials
        • Clinical Trials Regulation
        • Clinical Trials Directive
        • Good Clinical Practice (GCP) Inspections
        • GCP inspections – topics of interest
          • Serious breach reporting
          • Informed consent
          • Electronic Health Records (eHRs)
        • Safety reporting in clinical trials
        • Publication of clinical trial information
        • Guidance on the management of clinical trials during COVID-19
        • Contact information for clinical trials
      • Generic and Interchangeable Medicines
      • Manufacturers
      • Wholesale Distribution
      • Retailers
      • Market Compliance and Surveillance
      • Medicine Fees
      • Export Certification
      • Consultations
      • Product Information Update (PIU)
      • National Scientific and Regulatory advice
      • Information for Brokers
      • Active Substance Registrations
    • News & Events
    • Special Topics
    • Emergency Medicines
    • Emergency Contact Details
  • Veterinary
  • Medical Devices
  • Cosmetics
  • Controlled Substances
  • Blood, Tissues, Organs

GCP inspections – topics of interest

This section relates to topics of special interest. Each topic includes background information as well as links to further information where relevant. 

 
Serious breach reporting
 
Informed consent
 
Electronic health records (eHRs)


About Us

  • Our Mission, Vision and Values
  • What We Regulate and How We Regulate
  • Our Strategic Plan 2021 – 2025
  • Contact Us
  • Our Structure
  • Patient Forum
  • Publications & Forms
  • Standards of Service
  • Privacy and Data Protection
  • Information and transparency
  • Consultations
  • Quality Management
  • Recruitment
  • Report an Issue
  • Legislation
  • Extranets
  • News and Events
  • Information Campaigns

Medicines

  • COVID-19 vaccines and treatments
  • Our Role
  • Medicines Information
  • Safety Information
  • Safety Notices
  • Quality Information
  • Regulatory Information
  • News & Events
  • Special Topics
  • Emergency Medicines
  • Emergency Contact Details

Veterinary

  • Our Role
  • Veterinary Medicines Information
  • Safety Information
  • Regulatory Information
  • Veterinary News & Events
  • Special Topics
  • Contact details
  • Scientific Animal Protection

Medical Devices

  • COVID-19 Updates
  • Our Role
  • Safety Information
  • Regulatory Information
  • Registration
  • Medical Devices News & Events
  • Special Topics
  • Contact Medical Devices

Cosmetics

  • Our Role
  • Safety Information
  • Regulatory Information
  • News & Events
  • Special Topics

Controlled Substances

  • Our Role
  • Controlled Drugs
  • Precursor Chemicals

Blood, Tissues, Organs

  • Our Role
  • Blood
  • Tissues and Cells
  • Organs
  • Blood and Tissues Establishments List
  • Inspection Process
  • Special Topics
  • News and Events
  • Reporting Adverse Reactions / Events
  • Safety Topics

Website Information

  • Register for Alerts
  • Terms of Use
  • Privacy and Cookie
  • Contacts
  • Links
  • FOI
  • Sitemap
 

© Health Products Regulatory Authority 2014

Contact Us

Kevin O'Malley House, Earlsfort Centre, Earlsfort Terrace, Dublin 2, Ireland, D02 XP77

  • +353 (1) 676 4971
  • info@hpra.ie
  •  
  • Follow @TheHPRA
 
 

Developed by Engine Solutions

Date Printed: 20/03/2023